Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Central Europe Online .
Press releases published on June 2, 2025
Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY
GlobeNewswire
·
June 2, 2025
REYKJAVIK, Iceland, June 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Jefferies …
Diana Shipping Inc. Announces Time Charter Contract for m/v Newport News With Bohai Ocean Shipping
GlobeNewswire
·
June 2, 2025
ATHENS, Greece, June 02, 2025 (GLOBE NEWSWIRE) -- Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that through a separate wholly-owned …
High Grade Ni/PGE Adjoining Globex’s Tyrone Property
GlobeNewswire
·
June 2, 2025
ROUYN-NORANDA, Quebec, June 02, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang …
Evosep unveils new instrumentation and partnership at ASMS 2025
GlobeNewswire
·
June 2, 2025
BALTIMORE, Md., June 02, 2025 (GLOBE NEWSWIRE) -- Evosep®, a global leader in proteomics solutions, is proud to announce the launch of the Evosep Eno™, a robust, high-throughput separation tool preparing for next generation workflow integration for LC-MS …
AB Akola Group presentation during the Nasdaq Vilnius Stock Exchange’s traditional event, “CEO Meets Investors”
GlobeNewswire
·
June 2, 2025
On June 2, 2025, AB Akola Group's CFO, Mažvydas Šileika, shared a slide presentation with the investment community during the Nasdaq Vilnius Stock Exchange’s traditional event, “CEO Meets Investors”. Attached: presentation demonstrated during the event. …
AB Akola group pristatymas Nasdaq Vilniaus vertybinių popierių biržos renginio „Vadovai susitinka su investuotojais“ metu
GlobeNewswire
·
June 2, 2025
2025 m. birželio 2 d. AB Akola group finansų direktorius Mažvydas Šileika atliko pristatymą investuotojų bendruomenei tradicinio Nasdaq Vilniaus vertybinių popierių biržos renginio „Vadovai susitinka su investuotojais“ metu. Pridėta: renginio metu rodytos …
Oxylabs Unveils First-of-its-kind YouTube Datasets to Power Responsible AI
GlobeNewswire
·
June 2, 2025
The datasets fast-track video data from creator consent to AI-readiness VILNIUS, Lithuania, June 2, 2025 – Oxylabs, a leading web intelligence platform and proxy provider, introduces industry-first YouTube datasets composed entirely of consent-based data. …
Full Dose-Escalation Data Show Continued High Response Rates and Favorable Safety Profile of ISB 2001, a First-in-Class BCMA × CD38 × CD3 Trispecific Antibody, for the Treatment of Relapsed/Refractory Multiple Myeloma
GlobeNewswire
·
June 2, 2025
TRIgnite-1 study shows an overall response rate (ORR) of 74% across nine dose levels, in heavily pretreated patients with a median of six prior lines of therapy ORR is remarkably high in patients with no prior CAR-T or bispecific therapies (84%) as well as …
Sébastien Jacquet Appointed Chief Quality Officer
GlobeNewswire
·
June 2, 2025
Sébastien Jacquet Appointed Chief Quality Officer AMSTERDAM, June 2, 2025 – Stellantis N.V. today announced the appointment of Sébastien Jacquet as Chief Quality Officer, effective immediately. He succeeds Antonio Filosa, who has been appointed to be the …
Rakovina Therapeutics Announces 2025 Q1 Financial Results and Provides Corporate Update
GlobeNewswire
·
June 2, 2025
VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing novel DNA-damage response (DDR) cancer therapies powered by artificial …
Robex Reports Operational and Financial Results for Q1 2025
GlobeNewswire
·
June 2, 2025
QUÉBEC CITY, June 02, 2025 (GLOBE NEWSWIRE) -- Robex Resources Inc. ("Robex" or the "Company") (TSXV: RBX/ASX: RXR) Matthew Wilcox, Managing Director, commented: "The company has had a strong start to 2025, construction continues to advance at Kiniero, and …
Fancamp Announces Appointment of CIO
GlobeNewswire
·
June 2, 2025
VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Fancamp Exploration Ltd. (“Fancamp” or the “Corporation”) (TSX Venture Exchange: FNC) is pleased to announce the appointment of Mr. Kit Spring to the position of Chief Investment Officer (“CIO …
Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting
GlobeNewswire
·
June 2, 2025
31% confirmed ORR (8 responses in 26 evaluable patients) across B7-H4 high tumors at intermediate doses 44% confirmed ORR (7 responses in 16 evaluable patients) in the subset of patients with ≤4 prior lines of therapy CAMBRIDGE, Mass., June 02, 2025 (GLOBE …
COS Systems expands Open Access Services partnership with Fujitsu
EIN Presswire
·
June 2, 2025
Extended partnership enables turn-key Open Access network operations backed by COS Business Engine. WEST PALM BEACH, FL, UNITED STATES, June 1, 2025 /EINPresswire.com/ -- COS Systems continues to strengthen its partnership with Fujitsu, a leading …
ASML reports transactions under its current share buyback program
GlobeNewswire
·
June 2, 2025
ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average …
STMicroelectronics Announces Status of Common Share Repurchase Program
GlobeNewswire
·
June 2, 2025
STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from May 26, 2025 to May 30, 2025 AMSTERDAM – June 2, 2025 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global …
Enterome to present positive Phase 2 indolent non-Hodgkin lymphoma data for its OncoMimics™ EO2463 at ICML
GlobeNewswire
·
June 2, 2025
Presentation at the International Conference on Malignant Lymphoma (ICML) in Lugano on June 21 SIDNEY is an ongoing Phase 2 trial of EO2463 in 48 indolent Non-Hodgkin Lymphoma (iNHL) patients Enterome has held a positive Type-C meeting with FDA for …
Allarity Therapeutics Announces First Patient Enrolled in New Phase 2 Clinical Trial Protocol of Stenoparib in Advanced Ovarian Cancer
GlobeNewswire
·
June 2, 2025
TARPON SPRINGS, Fla., June 2, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway …
SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting
GlobeNewswire
·
June 2, 2025
- ASCO Presentation Supports SLS009 as a Potential Targeted Therapy for ASXL1 Mutated Colorectal Cancer – - 22,500 New Cases of Colorectal Cancer with High Microsatellite Instability per Year in the US: 55% ASXL1m Frequency – NEW YORK, June 02, 2025 (GLOBE …
Aventis Energy Announces Appointment of Michael Mulberry to the Board of Directors
GlobeNewswire
·
June 2, 2025
VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Aventis Energy Inc. (“Aventis” or the “Company”) (CSE: AVE | FRA: C0O0 | OTC: VBAMF), is pleased to announce that Mr. Michael Mulberry has been appointed to the board of directors of the …